Mayo Clinic Cardiovascular CME
The Cardiovascular CME podcast is a free educational offering from Mayo Clinic, featuring content geared towards physicians, physician assistants, and nurse practitioners who are interested in exploring a multitude of ca...
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Based on the show's feed history.
Built from
By chart position
- 🇷🇴RO · Education#1671.7K to 15K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.7K to 15K🎙 ~2x weekly·100 episodes·Last published yesterday - Monthly Reach
Unique listeners across all episodes (30 days)
3.3K to 30K🇺🇸71%🇷🇴29% - Active Followers
Loyal subscribers who consistently listen
1.8K to 17K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 10/27/26 | Choice of Anticoagulation | Choice of Anticoagulation Guest: Ana Casanegra, M.D., M.S. Host: Sharonne Hayes, M.D. This podcast will equip clinicians with a practical, patient-centered framework for selecting anticoagulants across common cardiovascular and thrombotic conditions. Listeners will learn how to balance efficacy, bleeding risk, comorbidities, and patient preferences when choosing among DOACs, warfarin, and other options. Real-world considerations and common clinical pitfalls will be highlighted to support confident, evidence-based anticoagulation decisions in daily practice. Topics Discussed: Anticoagulant selection: indication, thrombotic/bleeding risk, renal function, and patient factors DOACs vs warfarin: benefits, limitations, and appropriate use cases Anticoagulation strategies across AF, VTE, and vascular disease Dosing considerations in renal impairment, older adults, and weight extremes Common management pitfalls, bleeding risk assessment, and treatment optimization Emerging evidence and future trends in anticoagulation care Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on X: @MayoClinicCV LinkedIn: Mayo Clinic | LinkedIn Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 07-April-2026 | 14m 42s | ||||||
| 10/20/26 | The Athlete’s Heart Paradox: Managing Arrythmias at Peak Performance | The Athlete’s Heart Paradox: Managing Arrythmias at Peak Performance Guest: Guru Kowlgi, M.D.Host: Anthony Kashou, M.D. Exercise is one of the best prescriptions for cardiovascular health—but can there be too much of a good thing? In highly trained athletes, years of intensive exercise can produce electrical, autonomic, and structural changes that may increase susceptibility to arrhythmias, while in other cases exercise may uncover an underlying cardiac condition. Dr. Guru Kowlgi discusses how clinicians can distinguish normal adaptations of the athlete’s heart from warning signs that warrant further evaluation, including exertional syncope, declining performance, and increasingly complex ventricular arrhythmias. He also explores individualized treatment strategies, from medications to catheter ablation, and the growing role of shared decision-making when determining whether an athlete can safely return to competition. Finally, the discussion puts sudden cardiac death in athletes into perspective and highlights the importance of both identifying those at increased risk and being prepared with CPR and rapid access to AEDs when unexpected cardiac arrest occurs. Topics discussed: Why can sustained, high-level endurance training increase the risk of arrhythmias such as atrial fibrillation in some athletes? Which rhythm findings are normal adaptations of the athlete’s heart, and which symptoms or arrhythmias should raise concern? How can arrhythmias be treated while preserving an athlete’s ability to exercise, compete, and maintain performance? When might catheter ablation be preferable to medication for athletes with arrhythmias? Which underlying cardiac conditions increase the risk of sudden cardiac death in athletes, and how can clinicians, teams, and coaches prepare for cardiac emergencies? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on X: @MayoClinicCV LinkedIn: Mayo Clinic | LinkedIn Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recording date: 30-September-2026 | 14m 16s | ||||||
| 10/13/26 | The Cardiovascular Risks of Recreational Adderall Use | The Cardiovascular Risks of Recreational Adderall Use Guest: Anna Svatikova, M.D., Ph.D.Host: Paul Friedman, M.D. Adderall has become a popular “study drug” and performance enhancer among college students and young professionals—but what happens to the cardiovascular system when someone without ADHD takes it recreationally? Dr. Anna Svatikova discusses research showing striking changes in blood pressure, heart rate, and sympathetic nervous system activity after just one dose in healthy, Adderall-naive adults. She and Dr. Paul Friedman explore what these findings could mean for palpitations, chest pain, arrhythmias, and other cardiovascular complications seen in young adults. They also explain why these results should not be confused with the risks of appropriately prescribed ADHD treatment and consider what may happen when Adderall is combined with energy drinks, alcohol, smoking, or underlying cardiovascular disease. Topics discussed: Why has recreational Adderall use become so common among college students and young professionals? What happens to blood pressure, heart rate, and the sympathetic nervous system after a single dose of Adderall? Could recreational Adderall use contribute to palpitations, chest pain, arrhythmias, or more serious cardiovascular events? Why are the risks of recreational use different from medically supervised Adderall treatment for ADHD? How could underlying heart disease or combining Adderall with energy drinks, alcohol, or smoking amplify cardiovascular risk? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on X: @MayoClinicCV LinkedIn: Mayo Clinic | LinkedIn Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recording date: 02-June-2026 | 16m 35s | ||||||
| 10/6/26 | What Cardiologists Should Know About the Genetics of Thoracic Aortic Aneurysms | What Cardiologists Should Know About the Genetics of Thoracic Aortic Aneurysms Guest: David Deyle, M.D. Host: Kyle Klarich, M.D. Thoracic aortic aneurysms can have an underlying genetic cause that affects patient management, surveillance, surgical decision-making, and family screening. In this episode, listeners will learn when to consider genetic testing and clinical genomics consultation for patients with thoracic aortic disease, including those with suspected Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, and other familial aortopathies. The discussion also explores how to interpret genetic test results and variants of uncertain significance, the importance of family history and clinical phenotype, and how a genetic diagnosis can guide surveillance and treatment decisions. Topics discussed: When should clinicians consider genetic testing for thoracic aortic aneurysms and other aortic diseases? How can genetic findings influence aortic surveillance, surgical intervention, and screening of family members? How should positive and negative genetic test results and variants of uncertain significance be interpreted? What roles do family history, clinical phenotype, and age play in evaluating inherited thoracic aortic disease? When should cardiologists involve clinical genomics in patient care? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on X: @MayoClinicCV LinkedIn: Mayo Clinic | LinkedIn Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recording date: 16-March-2026 | 24m 43s | ||||||
| 9/29/26 | Transcatheter Valve Interventions | Transcatheter Valve Interventions Guest: Jared Bird, M.D. Host: Malcolm Bell, M.D. After listening to this podcast, listeners will be able to describe transcatheter treatment options for mitral valve disease, including transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR); identify key echocardiographic and cardiac CT findings used for patient selection and procedural planning; and discuss the evolving role of transcatheter mitral valve interventions in the treatment of mitral regurgitation and other forms of mitral valve disease. Topics discussed: What are TEER and TMVR, and how do these transcatheter mitral valve interventions differ from surgical mitral valve repair and replacement? How are transthoracic echocardiography, transesophageal echocardiography (TEE), and cardiac CT used to evaluate patients and plan transcatheter mitral valve procedures? Which patients with mitral regurgitation are candidates for TEER, and when might TMVR be a better treatment option? What anatomic and clinical factors influence the safety and success of transcatheter mitral valve interventions? How might TEER and TMVR shape the future treatment of mitral valve disease? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on X: @MayoClinicCV LinkedIn: Mayo Clinic | LinkedIn Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recording date: 23-June-2026 | 18m 01s | ||||||
| 9/22/26 | Thoracic Aortic Aneurysm in Women | Thoracic Aortic Aneurysm in Women Guest: Thais Coutinho, M.D. Host: Sharonne Hayes, M.D. After listening to this podcast, listeners will be able to describe sex differences in the epidemiology and outcomes of thoracic aortic aneurysm (TAA), explain the biological and physiological factors that contribute to these differences, and identify clinically applicable strategies to improve TAA outcomes in both women and men. Topics discussed: How does thoracic aortopathy differ between women and men? What factors contribute to sex differences in the incidence and outcomes of thoracic aortic aneurysm? What can clinicians do today to improve TAA outcomes in women? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on X: @MayoClinicCV LinkedIn: Mayo Clinic | LinkedIn Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 02-February-2026 | 17m 21s | ||||||
| 9/15/26 | How AI Can Assist in the Performance of Point of Care Ultrasound | How AI Can Assist in the Performance of Point of Care Ultrasound Guest: Jared Bird, M.D. Host: Kyle Klarich, M.D. Artificial intelligence is rapidly enhancing the performance of cardiac point-of-care ultrasound (POCUS) by improving image acquisition, providing easy-to-use tools for automated quantification, and reducing the impact of variability in user training on the acquisition of high-quality cardiac POCUS studies. AI-guidance solutions for obtaining high-yield cardiac POCUS views are helping both experienced clinicians and novice users acquire diagnostic-quality images for the rapid assessment of cardiac pathology. These AI tools serve as a powerful addition to the clinician's toolbox but do not replace comprehensive echocardiography or the expertise of trained healthcare providers. Topics Discussed: How do AI-guidance solutions improve the acquisition of cardiac point-of-care ultrasound images? Can AI meaningfully shorten the learning curve for trainees and nonexpert users? In what ways does AI enhance image interpretation and quantitative assessment in cardiac POCUS? What AI-guidance and interpretive solutions are currently available on the market? What are the limitations and challenges associated with integrating AI into bedside cardiac POCUS? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on X: @MayoClinicCV LinkedIn: Mayo Clinic | LinkedIn Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 05-March-2026 | 17m 39s | ||||||
| 9/8/26 | Cardioneural Ablation in Practice: Cases, Curves, and Clinical Impact | Cardioneural Ablation in Practice: Cases, Curves, and Clinical Impact Guest: Guru Kowlgi, M.B.B.S., M.S. Host: Anthony Kashou, M.D. In this episode of segment “ECG Making Waves” on Mayo Clinic podcast Interviews With the Experts, Dr. Anthony Kashou interviews Dr. Guru Kowlgi, a consultant in heart rhythm services at Mayo Clinic and assistant professor of medicine at the Mayo Clinic College of Medicine and Science. Listeners will hear a deep dive into real-world experience with cardioneural ablation, focusing on case volume, patient selection, and clinical outcomes. Topics Discussed: What clinical problem is cardioneural ablation trying to solve? Cover indications, both established and new How many cardioneural ablation cases have you performed to date? (How has case selection evolved over time?) What are your success rates? Any complications? Any concerns about long-term autonomic imbalance? What trials or data are still needed? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on X: @MayoClinicCV LinkedIn: Mayo Clinic | LinkedIn Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 01-May-2026 | 16m 58s | ||||||
| 9/1/26 | Epidemiology of Myocarditis | Epidemiology of Myocarditis Guest: Leslie Cooper, M.D. Host: Sharonne Hayes, M.D. Approximately 1,000,000 cases of myocarditis are diagnosed annually with an incidence of approximately 16/100,000. The incidence is highest in men between 15 and 45 years of age. However, after age 60 years, women have higher mortality than men. The overall mortality rate is 0.4/100,000. The rates of diagnosis are double in high SDI regions compared to low STI regions, most likely due to the availability of the pivot all diagnostic tests, cardiac MRI and heart biopsy. The incidence rates are stable while the death rates have decreased from 1990 to 2023. Finally, the causes of myocarditis or changing with more cases of immune checkpoint inhibitor related myocarditis which can affect between 0.2 and 1.1% of patients receiving these cancer therapies. Topics Discussed: How does the epidemiology of myocarditis help inform clinical practice for individual patient management? Are there clinically important sex differences in myocarditis incidence and mortality which practicing physician should be aware of? Are the causes of myocarditis changing? If so, how does a change in etiology affect management? For more information, review the study below: Klingel, K., Tschöpe, C., Yon, D.K. et al. Global epidemiology of myocarditis: disparities in age, sex and geography. Nat Rev Cardiol (2026). https://doi.org/10.1038/s41569-026-01276-w Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on X: @MayoClinicCV LinkedIn: Mayo Clinic | LinkedIn Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 01-April-2026 | 12m 36s | ||||||
| 8/25/26 | Chronic Total Occlusion | Chronic Total Occlusion Guest: Abhiram Prasad, M.D. Host: Paul Friedman, M.D. Chronic total occlusions are frequently encountered and are associated with complex coronary artery disease and diffuse atherosclerosis. Percutaneous coronary intervention is a suitable option for relieving angina in select patients who remain symptomatic despite optimal medical therapy. Success rates of over 80% can be routinely achieved by CTO operators with MACE rates of less than 5%. Topics Discussed: Who is the ideal patient for CTO PCI? Which practices in CTO PCI maximize success and minimize risk? Is there a role of viability testing when evaluating patients for CTO PCI? Is there a role for non-culprit CTO PCI for complete revascularization post AMI? Is there any new clinical trial data for CTO PCI? Are there any new devices for CTO PCI? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on X: @MayoClinicCV LinkedIn: Mayo Clinic | LinkedIn Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 14-April-2026 | 15m 05s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 8/18/26 | Tricuspid Repair and Replacement in the Cath Lab: A New Era | Tricuspid Repair and Replacement in the Cath Lab: A New Era Guest: Mackram Eleid, M.D. Host: Malcolm Bell, M.D. In this episode of “Interviews With the Experts,” Mayo Clinic consultant in interventional cardiology Dr. Mackram Eleid explored the evolving landscape of transcatheter therapies for tricuspid valve disease. Listeners will hear an overview of current indications, benefits, and risks associated with transcatheter tricuspid repair and replacement. The discussion highlighted key factors that influence the choice between repair and replacement, reviewed current evidence, and examined important knowledge gaps and emerging data that may shape future clinical practice. Topics Discussed: What is the current threshold to recommend tricuspid intervention in a patient TR? What are the strengths and weaknesses of transcatheter tricuspid repair versus replacement? What evidence in the field is still needed? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on X: @MayoClinicCV LinkedIn: Mayo Clinic | LinkedIn Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 18-January-2026 | 16m 02s | ||||||
| 8/11/26 | Aortic Stenosis in the Younger Patient in 2026 | Aortic Stenosis in the Younger Patient in 2026 Guest: Mackram Eleid, M.D. Host: Malcolm Bell, M.D. Dr. Malcolm Bell interviews Dr. Malcolm Eleid on the diagnosis and management of aortic stenosis in younger patients, as well as discussing patient-centered decision-making considerations for lifetime management of aortic stenosis. After review, listeners will understand current indications as well as advantages and disadvantages of transcatheter versus aortic valve replacement for younger patients with aortic stenosis. Topics Discussed: What factors are taken into account when considering lifetime management of aortic stenosis? Can valve in valve be performed inside of a transcatheter aortic valve replacement (TAVR) prosthesis? Who are the patients that are better served with surgical aortic valve replacement (SAVR)? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 28-January-2026 | 20m 37s | ||||||
| 8/4/26 | What Cardiologists Should Know About Aortic Pathology | What Cardiologists Should Know About Aortic Pathology Guest: Melanie Bois, M.D. Host: Malcom Bell, M.D. Is all aortic disease the same? In this episode, Dr. Melanie Bois reviews the major diagnostic categories of aortic disease and how they influence patient management, including surgical decision-making, surveillance, and genetic evaluation. The discussion involves the causes of heritable thoracic aortic aneurysms and highlights how pathology findings can provide important clues to underlying genetic syndromes. Finally, Dr. Bois outlines the spectrum of inflammatory aortic diseases and explore key differential diagnoses that help distinguish immune-mediated, infectious, and degenerative processes. Topics Discussed: Are there special diagnostic considerations for the ascending versus descending aorta? What causes aneurysmal dilatation in the ascending aorta? How does the underlying cause impact management? What should I be looking for in the pathology report? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 28-January-2026 | 15m 56s | ||||||
| 7/28/26 | Comparing Marfan Syndrome, Loeys-Dietz Syndrome, and Vascular EDS | Comparing Marfan Syndrome, Loeys-Dietz Syndrome, and Vascular EDS Guest: Juan Bowen, M.D. Host: Paul Friedman, M.D. Marfan syndrome, Loeys-Dietz syndrome, and vascular Ehlers-Danlos syndrome are clinical problems seen in an aortic clinic. Thoracic aortic aneurysm is a common feature, but the three conditions differ in the severity of aortic and arterial disease and in the types of extracardiac problems that require management. Making an accurate diagnosis is an essential first step in their successful management. Topics Discussed: What mutations cause Marfan syndrome, Loeys-Dietz syndrome, and the vascular Ehlers-Danlos syndrome? What is the natural history of these three conditions? How is aortic and vascular disease managed in these three conditions? What are the non-cardiac problems most often encountered in these three conditions? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 17-February-2026 | 18m 28s | ||||||
| 7/21/26 | Inflammatory Aortic Aneurysms | Inflammatory Aortic Aneurysms Guest: Kenneth Warrington, M.D. Host: Kyle Klarich, M.D. In this episode of “Interviews With the Experts,” the listener will learn how to identify the common signs and symptoms associated with inflammatory aortic disease, as well as understand the conditions associated with inflammatory aortic aneurysms. Dr. Kenneth Warrington, John F. Finn Minnesota Arthritis Foundation Professor and consultant in rheumatology at Mayo Clinic, reviews the latest imaging techniques and treatments for inflammatory aortic disease. Topics Discussed: How do patients with inflammatory aortic disease present in clinical practice? Which specific conditions are associated with inflammatory aortic aneurysms? How are inflammatory aortic aneurysms diagnosed? How are patients with inflammatory aortic aneurysms managed? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 15-January-2026 | 14m 53s | ||||||
| 7/14/26 | Pulsed Field Ablation for Atrial Fibrillation with Left Atrial Appendage Occlusion | Pulsed Field Ablation for Atrial Fibrillation with Left Atrial Appendage Occlusion Guest: Ammar Killu, M.B.B.S. Host: Anthony Kashou, M.D. In this episode of Interviews with the Expert: ECG Making Waves, host Dr. Anthony Kashou is joined by Dr. Ammar Killu to discuss the evolving role of combining pulsed field ablation (PFA) with left atrial appendage occlusion (LAAO) for patients with atrial fibrillation. Together, they explore the rationale for a combined approach, the potential advantages of PFA over conventional thermal ablation, and key procedural considerations for performing both interventions safely and effectively in a single session. Topics Discussed: Why consider combining pulsed field ablation and left atrial appendage occlusion in the same AF patient? What does PFA add compared with conventional thermal ablation when planning a combined ablation–LAAO strategy? What are the procedural caveats when PFA and LAAO are done concomitantly? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 26-June-2026 | 11m 53s | ||||||
| 7/7/26 | What the Cardiologist Needs to Know About Marfan Syndrome | What the Cardiologist Needs to Know About Marfan Syndrome Guest: Juan Bowen, M.D. Host: Malcolm Bell, M.D. The prevalence of Marfan syndrome is estimated to be 1 in 5,000 people. Approximately 75% of cases are inherited and 25% are de novo mutations. Marfan syndrome is caused by mutations in the gene encoding for fibrillin 1. Management includes protection of the aorta with medication, surveillance imaging, and timely preventive aortic repair. Extracardiac problems are less lethal but affect quality of life. Topics Discussed: What are the physical findings in Marfan syndrome? What is the relationship of fibrillin 1 to the TGF beta pathway? Which medications have been shown to have aortic protective effects? When should patients have aortic repair? How is pregnancy managed in Marfan syndrome? How should non cardiac problems be managed? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 14-January-2026 | 16m 01s | ||||||
| 6/30/26 | Contraception Decision Making for Pre-Menopausal Women with Cardiovascular Disease | Contraception Decision-making for Pre-menopausal Women with Cardiovascular Disease Guest: Margaret Long, M.D. Host: Marysia Tweet, M.D., M.S. This podcast discusses how to approach contraceptive counseling for premenopausal women with cardiovascular disease, emphasizing individualized decision-making based on pregnancy goals and medical risks. It highlights safer options—such as progestin-only methods and intrauterine devices—while cautioning against estrogen-containing contraceptives due to increased thrombotic risk. The discussion also reviews practical considerations for cardiologists, including managing contraception after cardiac events and coordinating care with specialists. Overall, it underscores that effective contraception is typically safer than pregnancy for patients with significant cardiac conditions Topics Discussed: How do you approach contraception decision making in a patient with cardiac disease? Are some contraception options safer than others? Are those options just as effective? Will a specific method affect blood pressure or cholesterol? Are there other side effects to be aware of? What if a patient has an adverse event such as a heart attack or pulmonary embolus while on oral contraception? What is your approach to those patients? What are the most important lessons you would like to share with cardiovascular specialists? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 23-January-2026 | 14m 45s | ||||||
| 6/23/26 | Differential Diagnosis and Workup of Thoracic Aortic Aneurysm | Differential Diagnosis and Workup of Thoracic Aortic Aneurysm Guest: Juan M. Bowen, M.D. Host: Malcolm R. Bell, M.D. Thoracic aortic aneurysms are often found as incidental findings on imaging done for other indications. In this episode, listeners will learn more about the approach the Mayo Clinic Marfan and Thoracic Aorta Clinic takes. We can often find the cause by taking a directed family history and personal history, by looking for key physical findings, and by obtaining appropriate imaging and often also genetic tests. Topics Discussed: What is the differential diagnosis in adult patients? What questions are most helpful in the patient history, and what physical findings should the examiner look for? What cardiac and vascular imaging should be done on the initial evaluation? When should genetic tests be considered? When should preventive aortic repair be considered? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 14-January-2026 | 13m 22s | ||||||
| 6/16/26 | The Central Role of Cardiac MRI in the Management of Heart Failure and Cardiomyopathy Patients | The Central Role of Cardiac MRI in the Management of Heart Failure and Cardiomyopathy Patients Guest: Gosia Wamil, M.D., Ph.D. Host: Malcolm R. Bell, M.D. Cardiac MRI is now central to heart failure care, moving beyond imaging to guide diagnosis and treatment. It distinguishes disease causes, identifies fibrosis and scar, and uncovers specific conditions in both HFrEF and HFpEF. By providing prognostic markers, it helps tailor therapies and improve outcomes—delivering the right treatment at the right time. In this episode of "Interviews With the Experts," Dr. Malcolm Bell interviews Dr. Gosia Wamil from Mayo Clinic London practice on the role of cardiac MRI in practice. Topics Discussed: When does CMR change the management decision? CMR findings Which CMR biomarkers truly predict outcomes—and how should clinicians act on them? From echo-first to CMR-led pathways: what should every HF service implement now? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 14-January-2026 | 18m 41s | ||||||
| 6/9/26 | AI in Imaging: How Will it Change What We Do | AI in Imaging: How Will it Change What We Do Guest: Tim Poterucha, M.D. Host: Kyle Klarich, M.D. Artificial intelligence (AI) is beginning to reshape how we acquire, interpret, and act on cardiovascular imaging, particularly echocardiography. In this episode, we’ll walk through how we got here—from the historical innovation arc of echo to modern AI tools that segment images, detect disease, and support interpretation—and discuss what is real, what is hype, and where the true clinical opportunities and risks lie. We’ll also explore what this means for practicing clinicians and trainees who are considering a future in imaging. Topics Discussed: When it comes specifically to cardiovascular imaging, what is the current role of AI, and why is imaging such a natural fit for these tools? What are the problems with how we interpret imaging now, and what are the risks of AI? What is hype right now, and what is real? Is AI going to replace cardiologists for medical imaging interpretation, and should cardiology fellows be worried about going into imaging with the rise of AI? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded 01-December-2025 | 27m 26s | ||||||
| 6/2/26 | Menopause Management In Women with Cardiovascular Disease | Menopause Management In Women with Cardiovascular Disease Guest: Chrisandra Shufelt, M.D. Host: Marysia Tweet, M.D., M.S. Listeners of this episode of “Interviews with the Experts” will gain a practical, evidence-based framework for managing menopausal symptoms in women with cardiovascular disease or elevated CVD risk. Through discussion of patient selection, menopause-specific cardiovascular risk factors, and the evolving data on hormone therapy. Listeners will leave better equipped to individualize care and counsel patients with confidence. Topics Discussed: Treatment for menopause symptoms in women with risk factors for CVD Appropriate candidates for hormone therapy Which cardiovascular risk factors are attributable to ovarian aging (menopause) versus chronological aging? What does the current evidence show regarding claims that menopausal hormone therapy prevents cardiovascular disease? How might the FDA’s removal of the black box warning from menopausal hormone therapy labeling affect clinician prescribing practices and patient decision-making? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 15-January-2026 | 27m 41s | ||||||
| 5/26/26 | Handheld Ultrasound and Detection of Valve and Other Structural Heart Disease | Handheld Ultrasound and Detection of Valve and Other Structural Heart Disease Guest: Jared Bird, M.D. Host: Paul Friedman, M.D. Handheld ultrasound is rapidly changing cardiovascular structural heart disease assessment by allowing clinicians and researchers to detect valvular and structural heart disease earlier and more accurately. Advances in AI imaging guidance and interpretation further bridge the gap between physical exam and formal comprehensive echocardiography. It is important to realize how complimentary handheld ultrasound can be in the early detection of structural heat disease but does not replace diagnostic echocardiography. Topics Discussed: How does handheld ultrasound improve upon the traditional physical exam when it comes to identifying valvular or structural heart disease? What are the most common valve or structural abnormalities that clinicians can reliably detect using handheld ultrasound today? How are we using handheld ultrasound to screen patients for structural heart disease in a research setting? How do AI-ECG and handheld ultrasound intersect to provide optimal screening of asymptomatic patients with structural heart disease? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 30-December-2025 | 19m 37s | ||||||
| 5/19/26 | What Do I Need to Know About Pulsed Field Ablation? | What Do I Need to Know About Pulsed Field Ablation? Guest: Christopher DeSimone, Host: Anthony Kashou, M.D. In this episode of “ECG Making Waves, hosted by Dr. Anthony Kashou with guest Dr. Christopher DeSimone, the focus is on understanding the evolution of ablation technology, particularly why the field has shifted toward pulsed field ablation. The conversation explores the key differences between traditional thermal ablation methods and pulsed field ablation, highlighting mechanisms, safety profiles, and clinical advantages. Additionally, it provides insight into what patients and clinicians can expect on the day of an ablation procedure, as well as important considerations for post-procedure follow-up and recovery. Topics Discussed: What is pulsed field ablation? What are some of the differences between risks seen with thermal ablation vs. those seen with pulsed field ablation? How does efficiency of the procedure or speed of the procedure change what you do for ablation? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on: 28-January-2026 | 18m 22s | ||||||
| 5/12/26 | Cardiovascular Care of the Masters Athlete | Cardiovascular Care of the Masters Athlete Guest: Kathryn Larson, M.D. Host: Sharonne Hayes, M.D. In this podcast, Dr. Kathryn Larson will discuss current research on the influence of exercise on cardiovascular physiology and health. Specifically, she will discuss her research on the effects of life-long endurance exercise exposures on cardiac function and exercise capacity, particularly as it pertains to female masters athletes. This unique population can serve as an important model of healthy cardiovascular aging and offer therapeutic insights into how exercise truly is an effective therapy. Topics Discussed: On a “big picture” scale, what is interesting and unique about older adults who continue to maintain a high level of exercise training? Aging and the accumulation of cardiac and non-cardiac diseases clearly impact cardiovascular function over time. What lessons can we learn from masters athletes on how things like aging, menopause, and cardiovascular disease interact with a life-long habit of exercise? What are some of the challenges that come with studying masters athletes? Is there such a thing as “too much exercise?” Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded on 09-December-2026. | 24m 40s | ||||||
Showing 25 of 100
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Mayo Clinic Cardiovascular CME
Peaked at #167 in RO, currently #167 in RO.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| RO | — | #167 | #167 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.